ERBB2 and breast cancer: Triple-negative breast cancer (TNBC) accounts for 10–15% of all breast cancers and is characterized by lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2).